CSPC Pharmaceutical-UnspoadrCSPCY
13F holders, Q2 2025 (June 30)2holders
0new positions
0sold out
$3.91avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding CSPC Pharmaceutical-Unspoadr (CSPCY) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($8K) and PNC Financial Services Group, Inc. ($1K).
- Company
- CSPC Pharmaceutical-Unspoadr
- Filed as
- 1SPC PHARM ADR (Q2 2025)
- CUSIP
- 12591J207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 19 shares bought and 30 shares sold, net −11 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | Reduce -1.5% | 1,965 | $8K |
| PNC Financial Services Group, Inc. | 0.00% | Add +6.6% | 306 | $1K |
"% of holder's portfolio" is CSPCY's weight in each manager's 13F, not the share of CSPC Pharmaceutical-Unspoadr the manager owns.